| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,247 |
16,037 |
$660K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,665 |
8,394 |
$516K |
| 71046 |
Radiologic examination, chest; 2 views |
2,545 |
2,278 |
$67K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
465 |
429 |
$42K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
374 |
363 |
$41K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
787 |
694 |
$37K |
| 87631 |
|
411 |
374 |
$34K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
615 |
560 |
$30K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
549 |
494 |
$28K |
| 95117 |
|
1,760 |
683 |
$23K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,330 |
1,233 |
$14K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
256 |
228 |
$13K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
215 |
193 |
$12K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
214 |
183 |
$10K |
| 71020 |
|
218 |
205 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
286 |
271 |
$7K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
127 |
122 |
$6K |
| 74019 |
|
167 |
154 |
$5K |
| 93000 |
|
332 |
300 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
547 |
351 |
$4K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
30 |
29 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
2,735 |
2,533 |
$4K |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
2,405 |
2,322 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
92 |
81 |
$3K |
| 90734 |
|
313 |
297 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
154 |
142 |
$3K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
26 |
12 |
$2K |
| 90670 |
|
201 |
197 |
$2K |
| 94060 |
|
41 |
41 |
$2K |
| 81002 |
|
818 |
755 |
$2K |
| 99406 |
|
283 |
250 |
$2K |
| 90656 |
|
179 |
169 |
$2K |
| 96127 |
|
445 |
430 |
$1K |
| 90715 |
|
113 |
105 |
$1K |
| Q3014 |
Telehealth originating site facility fee |
330 |
304 |
$777.84 |
| 90686 |
|
65 |
60 |
$770.70 |
| 82962 |
|
653 |
581 |
$561.22 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
45 |
45 |
$513.02 |
| 90633 |
|
57 |
52 |
$489.00 |
| 81025 |
|
77 |
62 |
$424.41 |
| 94760 |
|
89 |
76 |
$400.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
160 |
152 |
$353.09 |
| 90710 |
|
29 |
28 |
$280.00 |
| 90648 |
|
27 |
27 |
$263.40 |
| 71045 |
Radiologic examination, chest; single view |
15 |
14 |
$229.50 |
| 1159F |
|
10,332 |
8,474 |
$216.87 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
276 |
233 |
$74.91 |
| 81003 |
|
28 |
26 |
$55.29 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
39 |
39 |
$41.61 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
36 |
33 |
$24.14 |
| 3075F |
|
767 |
695 |
$16.79 |
| 3074F |
|
1,937 |
1,730 |
$16.77 |
| 82044 |
|
12 |
12 |
$8.13 |
| 3079F |
|
1,238 |
1,131 |
$0.03 |
| 3078F |
|
1,635 |
1,465 |
$0.02 |
| 1126F |
|
1,658 |
1,487 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
598 |
513 |
$0.00 |
| 1125F |
|
2,465 |
2,145 |
$0.00 |
| G9716 |
Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason |
167 |
158 |
$0.00 |
| 1034F |
|
45 |
40 |
$0.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
228 |
202 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
241 |
216 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
41 |
38 |
$0.00 |
| 1036F |
|
345 |
319 |
$0.00 |
| 3044F |
|
59 |
58 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
50 |
42 |
$0.00 |
| 1170F |
|
18 |
18 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
40 |
37 |
$0.00 |
| 99000 |
|
17 |
16 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
30 |
30 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
615 |
552 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
725 |
658 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
200 |
183 |
$0.00 |
| 1160F |
|
30 |
30 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
91 |
88 |
$0.00 |
| 3288F |
|
30 |
30 |
$0.00 |
| 3077F |
|
42 |
39 |
$0.00 |
| 1158F |
|
18 |
18 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
34 |
34 |
$0.00 |